Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cardiorenal Med. 2013 Apr;3(1):63-70. doi: 10.1159/000350397.

Cardiorenal syndrome type 4: a review.

Author information

  • 1Department of Nephrology and Dialysis, San Giovanni Di Dio Hospital, Agrigento, Vicenza, Italy ; International Renal Research Institute (IRRI), San Bortolo Hospital, Vicenza, Italy.

Abstract

There is a bidirectional and complex relationship between the heart and kidneys. This interaction is physical, chemical as well as biological and is also reflected in a strong connection between renal and cardiovascular diseases. Cardiorenal syndrome type 4 (CRS type 4) is characterized by primary chronic kidney disease (CKD) leading to an impairment of cardiac function, with ventricular hypertrophy, diastolic dysfunction, and/or increased risk of adverse cardiovascular events. The incidence of CKD is increasing, and CRS type 4 is becoming a major public health problem associated with a high morbidity and mortality. In this study, we briefly review the epidemiology and pathophysiology of CRS type 4, the role of biomarkers in its early identification, and its management.

KEYWORDS:

Biomarkers; Cardiorenal syndrome type 4; Cardiovascular events; Chronic kidney disease

PMID:
23946725
[PubMed]
PMCID:
PMC3743409
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
    Loading ...
    Write to the Help Desk